Immune to Cancer: The CRI Blog
-
Melanoma and Immunotherapy: Tara’s Journey to Become a Cancer Patient Advocate
Melanoma veteran Tara Ryan shares her experience with taking control of her health, resilience in the face…
-
AACR20 Day 2 Highlights: COVID-19, Adoptive Cell Therapy, and Checkpoint Immunotherapy Insights
The second day of AACR’s annual meeting heard from experts at cancer centers in COVID-19 hotspots around…
-
AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome
The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…
-
Esophageal Cancer Awareness Month: 2020 Immunotherapy Research Update
Promising new research, a variety of immunotherapy treatment combinations, and how we’re working toward a future immune…
-
How Immunotherapy for Esophageal Cancer is Making an Impact
Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…
-
Head and Neck Cancer Awareness Month: 2020 Immunotherapy Research Update
HPV’s connection to head and neck cancer, treatment options, side effects, and how we’re working toward a…
-
Defining Resistance to Treatment with Anti-PD-1/PD-L1 Immunotherapy
CRI's Vanessa M. Lucey, Ph.D, MBA, helps guide the design and analysis of future clinical trials involving…
-
CRI Scientists Fighting the Novel Coronavirus Pandemic
CRI’s focus on immunology research—while primarily aimed at curing cancer—also has contributed to advances in the treatment…
-
Meet the Five Inaugural Lloyd J. Old STARs
We spoke with the five inaugural CRI Lloyd J. Old STARs to learn more about their work…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.